lunes, 9 de enero de 2017

Ovarian Epithelial, Fallopian Tube, Primary Peritoneal Cancer (PDQ®)—Health Professional Version - National Cancer Institute

Ovarian Epithelial, Fallopian Tube, Primary Peritoneal Cancer (PDQ®)—Health Professional Version - National Cancer Institute


National Cancer Institute

Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)–Health Professional Version



SECTIONS

Changes to This Summary (01/05/2017)

Revised a standard treatment option for advanced-stage ovarian epithelial cancer, FTC, and PPC to surgery followed by chemotherapy and poly (ADP-ribose) polymerase (PARP) inhibitors.
The Surgery followed by chemotherapy and PARP inhibitors subsection was extensively revised.
This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
  • Updated: January 5, 2017

No hay comentarios:

Publicar un comentario